2L6T
Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide
Summary for 2L6T
Entry DOI | 10.2210/pdb2l6t/pdb |
Related | 2JNR 2L6S |
Descriptor | VIR-576 (1 entity in total) |
Functional Keywords | anti-viral polypeptide, gp41 fusion peptide, fp1-24, antiviral protein |
Total number of polymer chains | 1 |
Total formula weight | 2252.69 |
Authors | Forssmann, W.,The, Y.,Stoll, M.,Adermann, K.,Albrecht, U.,Barlos, K.,Busmann, A.,Can les-Mayordomo, A.,Gimenez-Gallego, G.,Hirsch, J.,Jimenez-Barbero, J.,Meyer-Olson, D.,Muench, J.,Perez-Castells, J.,Staendker, L.,Kirchhoff, F.,Schmidt, R.E. (deposition date: 2010-11-24, release date: 2011-01-19, Last modification date: 2011-07-13) |
Primary citation | Forssmann, W.G.,The, Y.H.,Stoll, M.,Adermann, K.,Albrecht, U.,Barlos, K.,Busmann, A.,Canales-Mayordomo, A.,Gimenez-Gallego, G.,Hirsch, J.,Jimenez-Barbero, J.,Meyer-Olson, D.,Munch, J.,Perez-Castells, J.,Standker, L.,Kirchhoff, F.,Schmidt, R.E. Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Sci Transl Med, 2:63re3-63re3, 2010 Cited by PubMed: 21178138DOI: 10.1126/scitranslmed.3001697 PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report